One year study of efficacy and safety of infliximab in the treatment of patients with ocular and neurological Behçet’s disease refractory to standard immunosuppressive drugs

AnnaRita Giardina, Angelo Ferrante, Francesco Ciccia, Maria Vadalà, Ennio Giardina , Giovanni Triolo

DOI: 10.1007/s00296-009-1213-z
Referenced 39 times
Share this paper
Use this link to share this page publicly